- Home >
- Life Sciences >
- Healthcare >
World Markets for Point of Care Diagnostics 2009-13
World Markets for Point of Care Diagnostics 2009-13
- Report price : $ 3 300
- Publication date : April 2009
- Length : 190 pages
World Markets for Point of Care Diagnostics 2009-13
Point of care diagnostics is one of the most dynamic parts of the diagnostics industry and an area where several major competitors are battling for market share. Point-of-care testing (POC) is defined as diagnostic testing at or near the site of patient care. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.
Manufacturers are increasingly introducing minimally invasive tests that can be easily performed on a patient’s saliva, urine, breath or other bodily by-products.
This report covers the following POC test segments with current market size and forecasts:
- Glucose
- Pregnancy/Ovulation
- Coagulation/PT
- Fecal Occult Blood
- Drugs of Abuse
- H. pylori
- HIV
- Cholesterol
- Other
- Glucose
- Critical Care
- Pregnancy
- Infectious Diseases
- Cardiac Markers
- Cholesterol/Lipids
- Coagulation/PT, ACT
- bA1c
- Hemoglobin
- Fecal occult blood
- Drugs of Abuse
- Bilirubin
In addition to the total POC diagnostic market, the report also covers the impact on POC markets of the following trends:
- Miniturization
- Digital Technology
- Aging Population
- POC Advantages and Disadvantages
- Emerging World Markets
- Consolidation in IVD
- Physician Office Labs
- Retail Clinics
- Wellness Initiatives
As a worldwide report, this report breaks up revenue for POC diagnostics in the following regions:
- U.S.
- Europe
- Asia
- Rest of World
This report is the result of primary and secondary research - interviews with experts in the POC diagnostics industry, a review of annual reports and news articles in the area of POC diagnostics, and the analysis of Kalorama's diagnostics experts, who have observed the industry for the past decade. The most important part of Kalorama's anlaysis is its superior analysis of company activities and their true significance in the marketplace. The following companies are examined in detail:
- 77 Elektronika Kft
- Abbott Diagnostics
- Acrongenomics Inc.
- AgaMatrix, Inc
- Agilent Technologies Inc
- Alere Medical Inc
- ARKRAY
- Axis-Shield plc
- Bayer Diabetes Care
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- BIOSAFE Medical Technologies, Inc.
- Biosign Technologies Inc.
- BodyTel Scientific Inc.
- Chembio Diagnostics, Inc.
- Chempaq A/S
- Cholestech Corporation
- Concateno Plc / Cozart Plc
- Crescent Diagnostics Ltd.
- DexCom, Inc.
- Diabetech, LP
- Diazyme Laboratories
- DNA Direct, Inc.
- DNAFORM
- DNAPrint Genomics, Inc.
- EKF-diagnostic GmbH
- Epocal, Inc.
- Gentag Inc.
- Genzyme Corporation
- GlucoLight Corporation
- GlucoStats System
- GlucoTec, Inc.
- HealthPia America
- Heidelberger-Medical-Marketing GmbH (HMM GmbH)
- HemoCue AB
- Integrity Applications Ltd.
- Inverness Medical Innovations
- Lifescan Inc.
- Luminous Medical, Inc.
- Medtronic Inc.
- A. Menarini Diagnostics
- Menssana Research, Inc.
- Micronics Inc.
- Multilyte Limited
- MycroLab Pty Ltd.
- Neuroptix Corporation
- OraSure Technologies, Inc.
- OrSense Ltd.
- OrthoClinical Diagnostics.
- Philips Medical Systems
- PointCare Technologies, Inc.
- Polymedco, Inc.
- Quadraspec
- Qualigen, Inc.
- Quidel Corporation
- Quotient Diagnostics
- RainDance Technologies, Inc. (RDT)
- Roche Diagnostics
- SpheroSense Technologies Inc
- Taidoc Technology Corp.
- Veralight
LATEST REPORTS
Cambodia Pharmaceuticals and Healthcare Report Q3 2010
- $ 530
- July 2010
Cambodia?s pharmaceutical market was calculated to be worth KHR711bn (US$172mn) in 2009. BMI forecasts drug consumption to increase at a rate of 11.6% over the next five years to reach a value of KHR1,232bn (US$302mn) in 2014. Our long range forecast is for the market to reach KHR2,062bn (US$516mn) in ...
Industries : Healthcare, Pharmaceutical
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2010
- $ 530
- July 2010
According to BMI's drug expenditure forecast model, sales of pharmaceuticals in Sri Lanka are expected to increase from LKR38.97bn (U$339mn) in 2009 to LKR43.88bn (US$388mn) in 2010. Due to the strengthening rupee, this equates to 12.6% growth in local currency terms and 14.2% in US dollar terms. Although ...
Industries : Healthcare, Pharmaceutical
OTC Healthcare in Singapore to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in Singapore. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope* Contains information on:analgesics,medicated ...
Industries : Healthcare, Over-The-Counter Drug
OTC Healthcare in South Africa to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in South Africa. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope* Contains information on:analgesics,medicated ...
Industries : Healthcare, Over-The-Counter Drug
OTC Healthcare in South Korea to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in South Korea. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope*Contains information on:analgesics,medicated ...
Industries : Healthcare, Over-The-Counter Drug
OTC Healthcare in Spain to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in Spain. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope* Contains information on:analgesics,medicated ski ...
Industries : Healthcare, Over-The-Counter Drug
OTC Healthcare in Vietnam to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in Vietnam. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope* Contains information on:analgesics,medicated s ...
Industries : Healthcare, Over-The-Counter Drug
OTC Healthcare in Slovenia to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in Slovenia. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope*Contains information on:analgesics,medicated s ...
Industries : Healthcare, Over-The-Counter Drug
General Medical Practices in the UK
- $ 835
- July 2010
This is the replacement for IBISWorld's July 2010 edition of General Medical Practices in the UK report.About this IndustryThis Industry Market Research report from IBISWorld provides a detailed analysis of the General Medical Practices in the UK industry, including key growth trends, statistics, forecasts, ...
Industries : Medical Facility
OTC Healthcare in Finland to 2014
- $ 495
- July 2010
IntroductionThis databook provides key data and information on the OTC healthcare market in Finland. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.Scope* Contains information on:analgesics,medicated s ...
Industries : Healthcare, Over-The-Counter Drug
24/7 Customer Service
Contact Shadi now !
Related industries
reportlinker.com © Copyright 2010. All rights reserved